Committee opinion no. 640: Cell-free DNA screening for fetal aneuploidy

Obstetrics and Gynecology

Volumn 126, Issue 3, 2015, Pages e31-e37

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; DNA;

ALPHA FETOPROTEIN BLOOD LEVEL; ANEUPLOIDY; CELL FREE DNA SCREENING; CELL FREE SYSTEM; CHROMOSOME ABERRATION; CHROMOSOME REARRANGEMENT; DIAGNOSTIC TEST ACCURACY STUDY; DNA SCREENING; FETUS ECHOGRAPHY; HUMAN; LABORATORY DIAGNOSIS; MATERNAL SERUM SCREENING TEST; MULTIPLE PREGNANCY; PATIENT COUNSELING; PREDICTIVE VALUE; PRENATAL SCREENING; PRIORITY JOURNAL; REVIEW; RISK; RISK BENEFIT ANALYSIS; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEX CHROMOSOME ABERRATION; TRISOMY 13; TRISOMY 18; TRISOMY 21;

EID: 84939629649     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/01.AOG.0000471172.63927.b6     Document Type: Review

References (32)

1. Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. MatErnal BLood IS Source to Accurately diagnose fetal aneuploidy (MELISSA) Study Group [published erratum appears in Obstet Gynecol 2012; 120: 957]. Obstet Gynecol 2012; 119: 890-901. [PubMed] [Obstetrics & Gynecology
2. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485-7. [PubMed] [Full Text
3. Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999; 64: 218-24. [PubMed] [Full Text
4. Norton ME, Brar H, Weiss J, Karimi A, Laurent LC, Caughey AB, et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012; 207: 137.e1-137.e8. [PubMed] [Full Text
5. Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, et al. DNA sequencing of maternal plasma to detect Down syndrome: an interna-tional clinical validation study. Genet Med 2011; 13: 913-20. [PubMed
6. Sparks AB, Wang ET, Struble CA, Barrett W, Stokowski R, McBride C, et al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat Diagn 2012; 32: 3-9. [PubMed] [Full Text
7. Zimmermann B, Hill M, Gemelos G, Demko Z, Banjevic M, Baner J, et al. Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequenc-ing of polymorphic loci. Prenat Diagn 2012; 32: 1233-41. [PubMed] [Full Text
8. Bianchi DW, Parker RL, Wentworth J, Madankumar R, Saffer C, Das AF, et al. DNA sequencing versus standard prenatal aneuploidy screening. CARE Study Group. N Engl J Med 2014; 370: 799-808. [PubMed] [Full Text
9. Gil MM, Quezada MS, Revello R, Akolekar R, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 2015; 45: 249-66. [PubMed] [Full Text
10. Porreco RP, Garite TJ, Maurel K, Marusiak B, Ehrich M, van Den Boom D, et al. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively paral-lel genomic sequencing of DNA. Obstetrix Collaborative Research Network. Am J Obstet Gynecol 2014; 211: 365.e1-365.12. [PubMed] [Full Text
11. Dar P, Curnow KJ, Gross SJ, Hall MP, Stosic M, Demko Z, et al. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prena-tal aneuploidy testing. Am J Obstet Gynecol 2014; 211: 527.e1-527.e17. [PubMed] [Full Text
12. Nicolaides KH, Syngelaki A, Ashoor G, Birdir C, Touzet G. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol 2012; 207: 374.e1-374.e6. [PubMed] [Full Text
13. Palomaki GE, Deciu C, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collab-orative study. Genet Med 2012; 14: 296-305.[PubMed] [Full Text
14. Pergament E, Cuckle H, Zimmermann B, Banjevic M, Sigurjonsson S, Ryan A, et al. Single-nucleotide polymorphism-based noninvasive prenatal screen-ing in a high-risk and low-risk cohort. Obstet Gynecol 2014; 124: 210-8. [PubMed] [Obstetrics & Gynecology
15. Sparks AB, Struble CA, Wang ET, Song K, Oliphant A. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evalua-tion for trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012; 206: 319.e1-319.e9. [PubMed] [Full Text
16. Zhang H, Gao Y, Jiang F, Fu M, Yuan Y, Guo Y, et al. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146 958 pregnancies. Ultrasound Obstet Gynecol 2015; 45: 530-8. [PubMed] [Full Text
17. Norton ME, Jacobsson B, Swamy GK, Laurent LC, Ranzini AC, Brar H, et al. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med 2015; 372: 1589-97. [PubMed] [Full Text
18. Bianchi DW, Parsa S, Bhatt S, Halks-Miller M, Kurtzman K, Sehnert AJ, et al. Fetal sex chromosome testing by mater-nal plasma DNA sequencing: clinical laboratory experience and biology. Obstet Gynecol 2015; 125: 375-82. [PubMed] [Obstetrics & Gynecology
19. Ashoor G, Syngelaki A, Poon LC, Rezende JC, Nicolaides KH. Fetal fraction in maternal plasma cell-free DNA at 11-13 week's gestation: relation to maternal and fetal characteristics. Ultrasound Obstet Gynecol 2013; 41: 26-32. [PubMed] [Full Text
20. Willems PJ, Dierickx H, Vandenakker E, Bekedam D, Segers N, Deboulle K, et al. The first 3,000 Non-Invasive Prenatal Tests (NIPT) with the Harmony test in Belgium and the Netherlands. Facts Views Vis Obgyn 2014; 6: 7-12. [PubMed] [Full Text
21. Alamillo CM, Krantz D, Evans M, Fiddler M, Pergament E. Nearly a third of abnormalities found after first-trimester screening are different than expected: 10-year experi-ence from a single center. Prenat Diagn 2013; 33: 251-6.[PubMed
22. Gregg AR, Gross SJ, Best RG, Monaghan KG, Bajaj K, Skotko BG, et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med 2013; 15: 395-8. [PubMed] [Full Text
23. Norton ME, Jelliffe-Pawlowski LL, Currier RJ. Chrom-osome abnormalities detected by current prenatal screen-ing and noninvasive prenatal testing. Obstet Gynecol 2014; 124: 979-86. [PubMed] [Obstetrics & Gynecology
24. Srinivasan A, Bianchi DW, Huang H, Sehnert AJ, Rava RP. Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet 2013; 92: 167-76. [PubMed] [Full Text
25. Wapner RJ, Babiarz JE, Levy B, Stosic M, Zimmermann B, Sigurjonsson S, et al. Expanding the scope of nonin-vasive prenatal testing: detection of fetal microdeletion syndromes. Am J Obstet Gynecol 2015; 212: 332.e1-332.e9. [PubMed] [Full Text
26. Canick JA, Kloza EM, Lambert-Messerlian GM, Haddow JE, Ehrich M, van Den Boom D, et al. DNA sequencing of maternal plasma to identify Down syndrome and other tri-somies in multiple gestations. Prenat Diagn 2012; 32: 730-4. [PubMed] [Full Text
27. Huang X, Zheng J, Chen M, Zhao Y, Zhang C, Liu L, et al.Noninvasive prenatal testing of trisomies 21 and 18 by massively parallel sequencing of maternal plasma DNA in twin pregnancies. Prenat Diagn 2014; 34: 335-40. [PubMed] [Full Text
28. Curnow KJ, Wilkins-Haug L, Ryan A, Kirkizlar E, Stosic M, Hall MP, et al. Detection of triploid, molar, and vanishing twin pregnancies by a single-nucleotide polymorphism-based noninvasive prenatal test. Am J Obstet Gynecol 2015; 212: 79.e1-79.e9. [PubMed] [Full Text
29. Grati FR, Malvestiti F, Ferreira JC, Bajaj K, Gaetani E, Agrati C, et al. Fetoplacental mosaicism: potential implications for false-positive and false-negative noninvasive prenatal screening results. Genet Med 2014; 16: 620-4. [PubMed] [Full Text
30. Hall AL, Drendel HM, Verbrugge JL, Reese AM, Schumacher KL, Griffith CB, et al. Positive cell-free fetal DNA testing for trisomy 13 reveals confined placental mosaicism. Genet Med 2013; 15: 729-32. [PubMed] [Full Text
31. Osborne CM, Hardisty E, Devers P, Kaiser-Rogers K, Hayden MA, Goodnight W, et al. Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease. Prenat Diagn 2013; 33: 609-11. [PubMed] [Full Text
32. Osborne CM, Hardisty E, Devers P, Kaiser-Rogers K, Hayden MA, Goodnight W, et al. Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease. Prenat Diagn 2013; 33: 609-11. [PubMed] [Full Text